Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
23,137
Total Claims
$980K
Drug Cost
1,840
Beneficiaries
$533
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 3,186 Anesthesiology providers
+56%
Opioid rate vs peers
54.1% vs 34.8% avg
+26%
Cost per patient vs peers
$533 vs $422 avg
-31%
Brand preference vs peers
3.3% vs 4.7% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
54.1%
Opioid Rate
12,521
Opioid Claims
$706K
Opioid Cost
14.7%
Long-Acting Rate
This provider's opioid prescribing rate of 54.1% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 752 claims · $401K
Generic: 22,385 claims · $579K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Buprenorphine | 320 | $118K |
| Hydrocodone/Acetaminophen | 5,507 | $98K |
| Oxycodone Hcl/Acetaminophen | 3,530 | $94K |
| Oxycodone Hcl | 137 | $90K |
| Buprenorphine Hcl | 129 | $88K |
| Oxycodone Myristate | 109 | $66K |
| Pregabalin | 821 | $46K |
| Gabapentin | 2,792 | $39K |
| Levorphanol Tartrate | 12 | $34K |
| Tapentadol Hcl | 21 | $26K |
| Naloxegol Oxalate | 65 | $25K |
| Morphine Sulfate | 683 | $25K |
| Fentanyl | 257 | $21K |
| Tizanidine Hcl | 2,711 | $21K |
| Suvorexant | 40 | $18K |
Prescribing Profile
41
Unique Drugs
21.0
Anomaly Score
Patient Profile
67
Avg Age
64%
Female
1.48
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About